Pulse - Value Added
FRACTIONAL CRO · MARYLAND-BASED, NATIONWIDE · $0→$200M

Kory White

RevOps & Revenue Leadership

Get a free 30-minute revenue checkup — Kory reviews your pipeline and forecast, then names the 1–2 fixes that move revenue fastest. 25 yrs scaling teams $0→$200M.

Free 30-min revenue checkup →
Hire a Fractional CROHow We Help?LinkedInRésuméCRO Syndicate
← Library
Knowledge Library · pulse-tools
13/13 Gate✓ IQ Certified10/10?

How Do I Get My Medical Device Reps to Sell the Full Portfolio?

Pulse ToolsHow Do I Get My Medical Device Reps to Sell the Full Portfolio?
📖 4,115 words🗓️ Published Jul 18, 2026 · Updated Jul 20, 2026
Direct Answer

You get medical device reps to sell the full portfolio by changing what you measure and what you pay — not by exhorting them harder. Reps rationally protect the one mature line surgeons already reorder because that is the line the comp plan and the sales-board reward. Fix the measurement and the behavior follows. The mechanism is a weighted, multi-KPI portfolio scorecard: list every product line and behavior that matters in the territory (usually eight or nine — flagship implants or devices, capital equipment, disposables and consumables, the newest launch line, service and warranty contracts, in-service and surgeon training, new-account or facility opens, and surgeon adoption depth), give each a weight set with sales leadership, then score every rep 1 to 5 on each line. The rep's number is a composite: the sum of (weight × level) across all KPIs. A rep who is a level 5 on the flagship implant but a level 1 on the launch line, capital, and service scores low — and the low score is visible, coachable, and tied to pay.

Then you do three things that make the scorecard bite. First, publish the matrix so every rep sees exactly where they stand and what the next level requires. Second, wire the incentive to the composite, not to one line — pay attainment across weighted plan components so the easy single-line commission no longer maxes anyone out. Third, keep the weights live: when a launch lands, a GPO or IDN contract shifts, or a competitor moves, you re-weight overnight and the field re-aims the next day. Run this for two to three quarters with consistent coaching and the portfolio gaps close, because the only path to a higher number is selling more of the whole bag the company actually built and launched. Below is the full method — how to design the scorecard, wire compensation and coaching to it, choose tooling from free to enterprise, and avoid the failure modes that quietly kill it.

flowchart TD A[List every product line and behavior] --> B[Assign a weight to each KPI with leadership] B --> C[Score every rep 1 to 5 per line] C --> D[Composite = sum of weight times level] D --> E[Publish the matrix to the whole field] E --> F[Wire commission and coaching to the composite] F --> G[Re-weight when a launch or contract shifts] G --> C

Why Your Reps Sell One Line and Ignore the Rest

Before you redesign anything, understand why the pattern exists, because the wrong diagnosis leads to the wrong fix. The portfolio problem in device sales is almost never a talent problem. It is an economics and measurement problem, and reps are responding correctly to the incentives you actually set — which are often different from the ones you think you set.

The mature line is the path of least resistance. A flagship implant that surgeons have used for years reorders itself. The rep walks in, confirms the case schedule, keeps trays stocked, and books revenue with a fraction of the effort a new launch demands. A launch line, by contrast, requires evaluation meetings, value-analysis committee (VAC) approval, a trial period, in-servicing the OR staff, and often a head-to-head against an incumbent. If both lines pay the same commission rate against a single territory-revenue quota, the rep is being paid the same for five times the work. Any rational person concentrates on the easy line.

The single-number sales board rewards exactly this. When the only figure leadership celebrates is total territory revenue to quota, the rep who hit 105% entirely on one implant and the rep who hit 105% by moving the launch line, capital, and three service contracts look identical on the board. The company just lost the information it most needs — who is building the future book versus who is harvesting the past one — and it lost the lever to reward the difference.

Launches die in the field regardless of marketing spend. Marketing can fund a beautiful launch, run the peer-to-peer programs, and secure the KOL support, and it will still stall if the field-facing incentive never changes. The rep controls the last mile — whose case it goes into, which surgeon gets asked, whether the capital conversation even happens. If the scorecard is silent on the launch line, the launch is orphaned at the exact point of contact where it lives or dies.

Capital and service are structurally under-sold for a related reason: they are lumpy, long-cycle, and cross-functional. A capital placement can take two to four quarters and involves finance, biomed, and the C-suite, not just the surgeon. Service and warranty contracts feel like paperwork to a rep wired for the OR. Without explicit weight and explicit credit, these high-margin, sticky revenue streams get deprioritized every single week in favor of the next case.

The takeaway: reps are not lazy or disloyal to the portfolio. They are optimizing the number you put in front of them. Change the number, and you change the behavior — but only if the new number is credible, visible, and connected to pay.

How Do I Get My Medical Device Reps to Sell the Full Portfolio — figure 1

Build the Weighted Portfolio Scorecard

This is the core artifact. Done well, it is a single grid that any rep, manager, or RevOps analyst can read in ten seconds. Here is how to build one that survives contact with a real field force.

Step 1 — List every KPI, not just the flagship. Sit with sales leadership and write down the complete set of lines and behaviors a fully-performing rep produces. A typical medical device territory lands on eight or nine:

If a line is not on the matrix, the field will not chase it. Fewer than five KPIs and you lose portfolio breadth; more than about twelve and the grid becomes noise nobody can act on. Eight or nine is the practical sweet spot.

Step 2 — Assign weights that encode strategy. Weights are where leadership's priorities become math. Give each KPI a weight so the total is a clean base (100 points, or weights that sum to 1.0). If the strategic imperative this year is the launch line and capital drag-along, those two might carry 40–50% of the total weight combined, even though the flagship still generates the most raw revenue. That deliberate mismatch — weighting the future above the harvest — is the entire point. To set weights without a food fight, run a one-hour session where each leader independently ranks the lines by strategic priority, then average the rankings; disagreements almost always cluster on one or two lines, and you resolve those by testing both weight sets for a quarter and comparing composite spreads.

How Do I Get My Medical Device Reps to Sell the Full Portfolio — figure 2

Step 3 — Define the 1-to-5 levels concretely. A score is worthless if two managers would grade the same rep differently. Anchor each level with an observable, near-objective definition per KPI. For a launch line, level 1 might be "no VAC submissions filed," level 3 "trials running in two accounts," level 5 "adopted in three-plus accounts with reorders." For surgeon adoption, level 1 "single champion surgeon," level 5 "line is the default across the department." Write these anchors down and publish them alongside the matrix, so the score reflects reality and not the manager's mood.

Step 4 — Score every rep and compute the composite. The formula is deliberately simple: composite = Σ (weight × level) across all KPIs. A rep who is a level 5 on the flagship (weight 20) contributes 100 from that line, but if they are a level 1 on the launch (weight 25), capital (weight 15), and service (weight 10), those weighted lines contribute a fraction of what they could. The composite lands low, and — crucially — the grid shows *why*, cell by cell. The gap stops being a vague feeling and becomes a specific, assignable next move on the territory review.

Step 5 — Publish it. The scorecard only changes behavior if every rep can see their own row, their composite, and the gap to the next level on each line. Print it at the district meeting, put it in the CRM dashboard, review it one-on-one. Transparency is not a nicety here; it is the mechanism. A hidden scorecard is just a manager's private opinion.

Note what the grid reveals that a revenue number never could: a rep can be at quota and still have a mediocre composite because they got there on one line. That rep is a flight risk to the launch strategy, and the scorecard surfaces it a full year before the stalled launch shows up in the P&L.

Wire Compensation and Coaching to the Composite

A scorecard with no teeth is a poster. Two things give it teeth: money and management attention. Do both or the effect fades by Q2.

How Do I Get My Medical Device Reps to Sell the Full Portfolio — figure 3

Make the composite gate the bonus. The cleanest lever is to make composite score — not single-line revenue — the qualifier for bonus eligibility and accelerators. When the old "hit quota on one implant and coast" path stops paying at full freight, attention reallocates within a quarter. You do not need to blow up base commission; you need the *upside* — the bonus, the accelerator, the President's Club qualification — to key off the weighted composite. In practice, many device teams keep a modest per-transaction commission on every line (so reps still care about each sale) but reserve the meaningful money for hitting composite thresholds and for strategic-line multipliers: pay 1.5× to 2× the base rate on the launch line and on capital-plus-disposables bundles during the push window. The multiplier is the fastest, most legible way to say "this line matters more right now" in the language reps actually read — dollars.

Design the plan so the math is unarguable. Reps will reverse-engineer any comp plan within a pay period. Use that. Show each rep, on their own numbers, how moving one launch account from level 1 to level 3 changes both their composite and their check. When the connection is concrete and self-evident, you get compliance without a fight. When it is fuzzy or feels like a tax, you get resentment and gaming.

Keep the plan legal and clean. Multi-line device comp intersects with compliance — sunshine reporting, anti-kickback considerations, and fair-market-value discipline around training and service. Build the plan with your legal and compliance partners so the incentive to sell the full portfolio never becomes an incentive to do anything improper. This is one reason many teams administer complex plans in dedicated incentive-comp software rather than a spreadsheet: auditability.

Coach the lowest-weighted gap, not the loudest complaint. With the composite in hand, the territory review changes character. Instead of "how's the number," the conversation is "your composite is 62; the biggest weighted drag is the launch line at level 1 — let's build the VAC plan for your two best accounts." Coaching becomes specific, prioritized, and repeatable. Set a cadence: composite reviewed monthly one-on-one, district-level composite trends reviewed at each district meeting, weights reviewed quarterly by leadership. The cadence is what keeps the scorecard from going stale.

Recognize composite movers publicly. Money moves behavior; recognition sustains it. Call out the rep who dragged their launch line from level 1 to level 4, not just the rep with the biggest raw number. You are teaching the whole field what "winning" now means. Do this consistently for a couple of quarters and the definition of a top rep quietly shifts from "sells a lot of the easy thing" to "moves the whole portfolio" — which is the cultural change you were actually after.

The compensation-and-coaching loop closes the system: the composite sets the target, pay rewards the target, coaching supplies the how, recognition reinforces the identity, and the re-weighting keeps the whole thing pointed at this quarter's strategy rather than last year's.

How Do I Get My Medical Device Reps to Sell the Full Portfolio — figure 4

Tools That Support Full-Portfolio Selling

You can run this method on a spreadsheet, and many teams should start there. But as the field force and plan complexity grow, tooling removes the manual burden and the version-control chaos. Here is the honest market, from free to enterprise, organized by what job the tool does — because most teams end up combining a scoring layer, a comp layer, and a visibility layer rather than buying one thing.

Free / build-your-own scoring layer. A well-built spreadsheet (Google Sheets or Excel) is free and fully transparent: list the KPIs, set the weights, score 1 to 5, and let a formula roll the composite. It is the fastest way to prove the method works before you spend a dollar, and a capable regional manager can build one in an afternoon. The costs are your time to maintain it, the risk of a stale sheet nobody updates after a launch, and the version-control headache when every region keeps its own copy. The [PULSE Pulse Check Matrix](/tools/pulse-check) is this exact model pre-built — define the KPIs, weight what matters, score each rep 1 to 5, and it rolls every rep into one composite Pulse number in the browser, free, without the spreadsheet upkeep or the drift. Use either to build and pressure-test the matrix before layering paid tools on top.

Comp layer — where the teeth live for most teams. QuotaPath is the practical value pick for tying the composite to commission: it tracks attainment across multiple plan components, so you can weight several lines and show each rep how the mix drives their pay, with published tiers that start affordable and a free entry point for small teams. For larger, more complex plans, CaptivateIQ and Xactly are dedicated incentive-compensation platforms (custom, enterprise pricing) built to model and pay multi-component plans accurately at scale — flagship, launch, capital, and disposables at different rates — with the audit trail and forecasting that compliance-heavy device orgs need. Choose these when the full-portfolio strategy is enforced primarily through pay and the plan has outgrown a spreadsheet's ability to be trusted.

CRM / system-of-record layer. Veeva CRM is the life-sciences standard and can host a weighted rep scorecard through dashboards built on your call, sample, and order data. It will not hand you the matrix out of the box — you build the report logic — but it already holds every input the composite needs (product mix by line, account coverage, surgeon adoption, activity), with compliance built in, so there is no double entry. The cost is build-and-admin overhead: someone owns the report and re-tunes it each time leadership re-weights. Best when you are already standardized on Veeva and want the scorecard living next to the field activity it measures.

Visibility / motivation layer. Ambition is the closest paid cousin to the matrix method — genuinely multi-KPI weighted scorecards piped onto TVs, Slack, or Teams and tied to coaching cadences — strong for larger field forces that want the scorecard automated off the CRM. Spinify and Hoopla lean toward gamification: leaderboards, competitions, and real-time recognition that keep full-portfolio behaviors top of mind during a launch quarter. They favor motivation over rigorous weighting, so they pair best with a matrix you define elsewhere. Use these when your field responds to visible competition and public scoreboards.

Conversation-intelligence complement. Gong (and similar revenue-intelligence platforms) scores what actually happens in surgeon and committee calls — whether reps are even *raising* the launch line and capital in the room, not just the easy reorder. It adds a behavioral, leading-indicator dimension the numbers miss and feeds the coaching side of the matrix real signal. It is a complement, not a scorecard or comp tool, and it carries call-capture compliance requirements you must clear first in a clinical setting.

How Do I Get My Medical Device Reps to Sell the Full Portfolio — figure 5

How to choose, in order:

  1. Define the KPIs and weights first. Every tool works better once the matrix exists. Build it (free) before you buy.
  2. Decide where the teeth live — visibility, commission, or both — and buy for that job.
  3. Make it visible to reps. The scorecard only changes behavior if every rep sees their levels and the gap to the next one.
  4. Keep it re-weightable. Favor tools whose weights you control, so you can pivot overnight when a launch lands or a contract shifts.
  5. Prove it free first, then add automation or comp software once you have outgrown the spreadsheet.

Common Failure Modes and How to Avoid Them

Teams that try this and fail usually trip on one of a handful of predictable rocks. Knowing them in advance is most of the battle.

Too many KPIs. A matrix with fifteen lines is a matrix nobody acts on. The composite becomes a black box, reps cannot tell which lever moves it, and coaching loses focus. Cap it at eight or nine, and if a new priority appears, retire a low-value line to make room rather than piling on.

Weights that never change. The single greatest advantage of this system is that you can re-aim the whole field overnight by adjusting weights when a launch lands or a GPO contract shifts. Teams that set weights once at the start of the fiscal year and freeze them throw that advantage away and let the scorecard drift out of sync with strategy. Review weights quarterly at minimum; change them the day a material shift happens, and communicate the change with a short runway so nobody feels ambushed at payout.

How Do I Get My Medical Device Reps to Sell the Full Portfolio — figure 6

A scorecard with no money attached. If the composite is a report but pay still keys off single-line revenue, reps read the real incentive and ignore the poster. The composite must gate bonus eligibility, accelerators, or club qualification, or it will not survive contact with a busy quarter.

Subjective, inconsistent scoring. If level definitions are vague, two managers grade the same rep differently, reps cry favoritism, and trust collapses. Anchor every level to an observable, near-objective condition, publish the anchors, and spot-audit scores across districts for consistency.

Punishing instead of coaching the gap. The scorecard is a diagnostic, not a weapon. A rep at level 1 on the launch line needs a VAC plan and air cover, not a public flogging. Teams that use the grid to shame reps get gaming and attrition; teams that use it to target coaching get the gap closed. Frame every low cell as the next assignable move.

Ignoring the ramp. A rep hired mid-year, or a territory just handed a brand-new launch line, cannot be at level 5 on everything by design. Build ramp expectations into the thresholds — grade against a fair curve for tenure and territory maturity — or you will drive out good early-tenure reps who are doing exactly the right things but have not had time to show level-5 results yet.

Set-and-forget tooling. A tool that automates the scorecard but is never re-tuned when the plan changes is worse than a spreadsheet someone actually maintains. Whatever layer you buy, assign an owner who re-tunes the logic every time leadership re-weights. The tool is only as current as the person tending it.

Avoid these six and the method compounds: each quarter the composite spread tightens, the launch lines move, and the definition of a top rep quietly becomes "moves the whole portfolio." That cultural shift — not the software — is the durable win.

FAQ

What if my reps just ignore the new scorecard? If the scorecard is visible and the composite gates bonus eligibility, most reps adjust within a quarter. The key is making the composite the single number that determines upside — bonus, accelerators, club qualification. When the old "hit quota on one line and coast" path stops paying at full freight, attention follows the money. Reps who still ignore it after a full quarter of visible, paid consequences are usually a coaching or fit issue, not a scorecard issue, and the grid will have already told you exactly which lines they are avoiding.

How many product lines should I include in the scorecard? Most territories work best with eight or nine lines — flagship implants, capital equipment, disposables, a launch line, service contracts, in-service training, new-account opens, and surgeon adoption. Fewer than five and you lose portfolio breadth; more than about twelve and the composite becomes a black box reps cannot act on. If you need to add a new priority, retire a low-value line rather than pushing past a dozen.

Can I change the weights after the year starts? Yes — and you should. Re-weighting mid-year is the system's biggest advantage, not a bug. When a new launch lands or a GPO or IDN contract shifts terms, adjust the weights overnight and the field re-aims the next day because the composite resets. The only discipline required is clear communication and, where pay is affected, a short runway so no one feels ambushed at payout. Review weights quarterly at minimum and change them the day a material shift happens.

What if my reps are strong on capital but weak on disposables? That is exactly the pattern the scorecard is built to catch. A level 5 on capital paired with a level 1 on disposables pulls the composite down and makes the gap a specific, assignable coaching item rather than a vague sense that "attachment could be better." Because disposables are the recurring, high-margin annuity attached to the capital they already placed, closing that gap is usually the fastest ROI on the whole grid. Over two to three quarters of targeted coaching, expect the gap to narrow measurably.

How do I get sales leadership to agree on the weights? Run a one-hour session where each leader independently ranks the product lines by strategic priority, then average the rankings. Disagreements almost always cluster on one or two lines. Resolve those by running both weight sets for a quarter and comparing the composite spreads and the actual line-level movement — let the data settle the argument rather than the loudest voice. Revisit the exercise each quarter as strategy evolves.

Is there a free way to build this scorecard before I buy software? Yes. A well-built spreadsheet is free and fully transparent — list the KPIs, set weights, score 1 to 5, and let a formula compute the composite. The free PULSE Pulse Check Matrix is the same model pre-built and shareable, so you avoid the version-control drift and stale-sheet risk. Prove the method works with one of these first, then add a comp or visibility layer only once you have outgrown the manual version.

Sources

flowchart TD subgraph SCORE[Per-rep scoring grid] K1[Flagship weight 20 x level] --> C[Composite score] K2[Launch line weight 25 x level] --> C K3[Capital weight 15 x level] --> C K4[Disposables weight 10 x level] --> C K5[Service weight 10 x level] --> C K6[Training weight 8 x level] --> C K7[New account opens weight 7 x level] --> C K8[Surgeon adoption weight 5 x level] --> C end C --> D{Composite vs threshold} D -->|Above| E[Bonus eligible and coach to stretch] D -->|Below| F[Targeted coaching on lowest weighted gap] F --> K2

Related on PULSE

Download:
Was this helpful?  
⌬ Apply this in PULSE
Pulse CheckScore reps on the metrics that matterGross Profit CalculatorModel margin per deal, per rep, per territoryHow-To · SaaS ChurnSilent revenue killer playbook